Literature DB >> 19767120

Assessment of hepatic insulin degradation, in normoglycemic hypertensive patients, by minimal modelling of standard intravenous glucose tolerance test data.

Francesco Di Nardo1, Massimo Boemi, Roberto Burattini.   

Abstract

Role of hepatic insulin degradation in modulating insulin delivery to peripheral circulation, in insulin-resistant hypertensive patients, is not yet fully understood. This issue was investigated here by a novel application to hypertension of a previously proposed minimal modelling of insulin and C-peptide data, using population values for insulin and C-peptide kinetics parameters. Data, from frequently sampled intravenous glucose tolerance test (FSIGTT), were analysed in ten normoglycemic, hypertensive patients (H-group), compared with eight normoglycemic, normotensive subjects (N-group), matched for age, gender and body mass index. Minimal modelling of C-peptide and insulin data provided beta-cell responsiveness to glucose perturbation (first, Phi(1), second, Phi(2), and basal, Phi(b), phase), insulin secretion rate, ISR(t) and total pre-hepatic insulin secretion, TIS, as well as insulin delivery rate, IDR(t), and total insulin delivery, TID, into plasma, over 5-h test. Instantaneous normalized hepatic insulin degradation rate was computed as HIDR(t)=1-[IDR(t)/ISR(t)]. In our H-group, insulin sensitivity, S(I), assessed by minimal model of glucose kinetics, showed a 56% reduction, which confirmed deterioration of insulin action in hypertension. This was associated with significant increase in Phi(1) (105%), TIS (55%) and TID (62%). No significant alterations were observed in other characteristic parameters of secretion and hepatic degradation of insulin, such that no significant difference was observed in HIDR(t) between our H and N groups. In conclusion, an increase of first phase and total insulin secretion occurring, in our H-group, in the presence of no alteration of hepatic insulin degradation, resulted in up-regulation of total insulin delivered to plasma (TID) for insulin-resistance compensation. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767120     DOI: 10.1016/j.cmpb.2009.08.007

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  3 in total

1.  Dynamics of insulin action in hypertension: assessment from minimal model interpretation of intravenous glucose tolerance test data.

Authors:  Roberto Burattini; Micaela Morettini; Francesco Di Nardo; Massimo Boemi
Journal:  Med Biol Eng Comput       Date:  2011-03-30       Impact factor: 2.602

2.  C-Peptide-based assessment of insulin secretion in the Zucker Fatty rat: a modelistic study.

Authors:  Francesco Di Nardo; Carla E Cogo; Emanuela Faelli; Micaela Morettini; Laura Burattini; Piero Ruggeri
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

3.  IVGTT-based simple assessment of glucose tolerance in the Zucker fatty rat: Validation against minimal models.

Authors:  Micaela Morettini; Emanuela Faelli; Luisa Perasso; Sandro Fioretti; Laura Burattini; Piero Ruggeri; Francesco Di Nardo
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.